Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment.

Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment.

Item
http://www.wikidata.org/entity/Q33395123
Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction.Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy.The interconnectedness of cancer cell signaling.Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessationVEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA.Cancer subclonal genetic architecture as a key to personalized medicine.Concise Review: Pancreatic Cancer and Bone Marrow-Derived Stem Cells.Plasma thrombospondin 1 as a predictor of postoperative liver dysfunction.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationPhase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma.Novel microspheres based on triterpene saponins from the roots of Physospermum verticillatum (Waldst & Kit) (Apiaceae) for the improvement of gemcitabine release.
P2860

Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment.

Item
http://www.wikidata.org/entity/Q33395123
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Myelosuppression of thrombocyt ...... erapy and anti-VEGF treatment.
@ast
Myelosuppression of thrombocyt ...... erapy and anti-VEGF treatment.
@en
type
label
Myelosuppression of thrombocyt ...... erapy and anti-VEGF treatment.
@ast
Myelosuppression of thrombocyt ...... erapy and anti-VEGF treatment.
@en
prefLabel
Myelosuppression of thrombocyt ...... erapy and anti-VEGF treatment.
@ast
Myelosuppression of thrombocyt ...... erapy and anti-VEGF treatment.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Myelosuppression of thrombocyt ...... erapy and anti-VEGF treatment.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932